These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22210920)

  • 1. A case of estrogen receptor positive secretory carcinoma in a 9-Year-old girl with ETV6-NTRK3 fusion gene.
    Yorozuya K; Takahashi E; Kousaka J; Mouri Y; Yoshida M; Fujii K; Akizuki M; Nakano S; Fukutomi T; Umemoto Y; Yokoi T; Imai H
    Jpn J Clin Oncol; 2012 Mar; 42(3):208-11. PubMed ID: 22210920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of quadruple primary malignancies including breast, tongue, and thyroid cancers and osteosarcoma in a young female without karyotype abnormality.
    Kousaka J; Fujii K; Yorozuya K; Mouri Y; Yoshida M; Nakano S; Fukutomi T; Takahashi E; Yokoi T
    Breast Cancer; 2014 Jul; 21(4):500-3. PubMed ID: 21562838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual.
    Grabellus F; Worm K; Willruth A; Schmitz KJ; Otterbach F; Baba HA; Kimmig R; Metz KA
    Breast; 2005 Feb; 14(1):71-4. PubMed ID: 15695086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.
    Vasudev P; Onuma K
    Arch Pathol Lab Med; 2011 Dec; 135(12):1606-10. PubMed ID: 22129193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
    Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
    Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary analog secretory carcinoma of salivary glands: a report of 2 cases with expression of basal/myoepithelial markers (calponin, CD10 and p63 protein).
    Laco J; Švajdler M; Andrejs J; Hrubala D; Hácová M; Vaněček T; Skálová A; Ryška A
    Pathol Res Pract; 2013 Mar; 209(3):167-72. PubMed ID: 23357688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Cutaneous Mammary Analog Secretory Carcinoma With ETV6-NTRK3 Translocation.
    Amin SM; Beattie A; Ling X; Jennings LJ; Guitart J
    Am J Dermatopathol; 2016 Nov; 38(11):842-845. PubMed ID: 27763904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
    Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
    Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
    Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
    Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off.
    Reynolds S; Shaheen M; Olson G; Barry M; Wu J; Bocklage T
    Head Neck Pathol; 2016 Sep; 10(3):405-13. PubMed ID: 27075025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
    Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
    Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
    Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
    J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory carcinoma of the breast with a cystically dilated intraductal component: report of a case.
    Izumi J; Komaki K; Hirokawa M; Masuda E; Monden Y
    Surg Today; 2003; 33(2):110-3. PubMed ID: 12616371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
    Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
    Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathological features of mammary analogue secretory carcinoma--review of literature.
    Takeda M; Kasai T; Morita K; Takeuchi M; Nishikawa T; Yamashita A; Mikami S; Hosoi H; Ohbayashi C
    Diagn Cytopathol; 2015 Feb; 43(2):131-7. PubMed ID: 24652816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.